Late-breaking findings revealed that IASO206, a cutting-edge BCMA-targeted in vivo CAR-T cell therapy, prompted the formation of functional CAR-T cells...
-
-
Recent Updates
- U.S. Army Eyes 75-Year Rare Earth Lease to Counter China
- Zuellig Pharma Expands Clinical Trial Supply Operations in China with Hangzhou Acquisition
- China Stock Debut Turns Former Teacher and Sister into Billionaires
- Oriental Culture Holding LTD. Returns to Profit as China Art Services Strategy Takes Shape
- Inside the Shanghai Grand Opera House, a US$590 million performing arts marvel
- Guangzhou airport reclaims title as China’s busiest
- China Deals Lead Startup Funding as AI Infrastructure Draws Fresh Capital
- Taiwan Sea Drone Firms Chase Funding as China Threat Shapes Defense Push
- China reveals plans for “world-first” floating island designed for months at sea
- Dematic and Nanhua Electromechanical Advance Smart Warehouse Project in China
Blogroll